The guest on this week's nationally syndicated Motley Fool Money radio show is Ron Adner, an award-winning professor and author of the new book The Wide Lens: A New Strategy for Innovation. In the past decade, major pharmaceutical companies such as Eli Lilly, Pfizer, and MannKind were in a race to be the first to market an inhalable insulin. In this audio segment, Adner details how Pfizer did everything right, only to fail on a massive scale. Adner provides shareholders of pharmaceutical companies a key insight into what those companies need if they want to succeed in creating the next blockbuster drug.
Full-time host of the Motley Fool Money radio show, MarketFoolery podcast, and other things. Part-time connoisseur of movies, basketball & fine bourbon.
Updated: Apr 7, 2017 at 7:01PMPublished: Feb 25, 2012 at 12:00AM